BIO welcomes EPA proposed rule on new RFS2 pathways.

Press Release Summary:



BIO welcomed public comment on proposed Renewable Fuel Standard amendments and clarifications, which include new pathway determinations for advanced biofuels such as isobutanol and ethanol from crop residues. Brent Erickson, EVP of BIO's Industrial and Environmental Section, said, "Finalization of new pathways will clear the way for companies to bring innovative technologies to the marketplace. Delays can determine whether these companies succeed or fail and whether investors remain confident."



Original Press Release:



BIO Welcomes EPA Proposed Rule on New RFS2 Pathways



WASHINGTON--The Biotechnology Industry Organization (BIO) today welcomed the opportunity for public comment on proposed Renewable Fuel Standard (RFS2) amendments and clarifications, which include new pathway determinations for advanced biofuels such as isobutanol and ethanol from crop residues.



“Finalization of new pathways will clear the way for companies to bring innovative technologies to the marketplace. Delays can determine whether these companies succeed or fail and whether investors remain confident. We look forward to working with EPA to rapidly finalize these new rules.”



Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, said, “We appreciate EPA moving forward as rapidly as possible with these program amendments. Companies continue to make investments, put steel in the ground, create jobs and develop technologies that reduce dependence on foreign oil and contribute to a cleaner environment. They are preparing to make additional investments with assurance that U.S. policy is committed to energy security and production of biofuels.



“Finalization of new pathways will clear the way for companies to bring innovative technologies to the marketplace. Delays can determine whether these companies succeed or fail and whether investors remain confident. We look forward to working with EPA to rapidly finalize these new rules.”



About BIO

BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.



Upcoming BIO Events



World Congress on Industrial Biotechnology

June 16-19, 2013

Montreal, Canada



BIO Investor Forum

October 8-9, 2013

San Francisco, CA



BIO IPCC Conference

November 6-8, 2013

Washington, DC



BIO Convention in China

November 11-13, 2013

Beijing, China



Pacific Rim Summit on Industrial Biotechnology & Bioenergy

December 8-11, 2013

San Diego, CA



BIO CEO & Investor Conference

February 10 – 11, 2014

New York, NY



Contacts

Biotechnology Industry Organization (BIO)

Paul Winters, 202-962-9237

Web: www.bio.org

Blog: www.biotech-now.org

Twitter: @IAmBiotech

All Topics